Welcome to our dedicated page for Flora Growth news (Ticker: FLGC), a resource for investors and traders seeking the latest updates and insights on Flora Growth stock.
Flora Growth Corp. (NASDAQ: FLGC), which has obtained shareholder approval to rebrand as ZeroStack, generates news that reflects its transition into a decentralized AI treasury company and its ongoing role as a global pharmaceutical distributor. Company announcements emphasize its strategy of accumulating $0G, the native cryptocurrency of the 0G AI infrastructure project, and its intention to position itself as a publicly listed 0G treasury.
Recent news releases highlight several themes. Flora has reported multiple private placement transactions involving common shares, pre-funded warrants, common share purchase warrants and convertible notes, with proceeds and tokens earmarked for its digital asset treasury strategy linked to $0G. The company has also announced specific purchases of $0G tokens, describing these as milestones in its mission to provide equity-based exposure to decentralized AI.
Corporate governance and capital markets developments are another recurring news topic. Flora has issued updates on its 2025 Annual and Special Meeting of Shareholders and a subsequent Special Meeting, where shareholders voted on director elections, amendments to the 2022 Incentive Compensation Plan, a share consolidation authority, a forward share split authority, the name change to ZeroStack, and approvals related to private placement issuances. The company has also reported on its 1-for-39 share consolidation and its successful effort to regain compliance with Nasdaq’s minimum bid price requirement.
Operational and strategic updates appear in news about Flora’s appointment of BitGo Trust Company, Inc. as custodian for its $0G treasury and its establishment of a crypto portfolio that includes Ethereum, Solana, Sui and Ripple. Other communications discuss its pharmaceutical distribution activities in Europe and its interest in German cannabis regulatory developments. Investors and observers can use this news feed to follow how Flora’s decentralized AI treasury strategy, financing activities, governance decisions and pharmaceutical distribution initiatives evolve over time.
Flora Growth Corp. (NASDAQ: FLGC) is hosting a webinar today, February 11, at 1:00 p.m. ET, led by CEO Luis Merchan. The session, part of the 'State of Play' series, will cover the CBD industry’s opportunities and challenges in North America, Latin America, and the EU. Interested participants can register through the provided link and submit questions in advance. Flora Growth is recognized for its outdoor cannabis cultivation, supplying products across several sectors including cosmetics and food.
Flora Growth Corp. (NASDAQ: FLGC) announced the appointment of James Choe as Chief Strategy Officer, enhancing its executive team following the acquisition of Vessel, a premium cannabis consumption brand. Choe, an experienced entrepreneur, aims to strengthen Flora's focus on people, design, and community within the cannabis market. The CEO, Luis Merchan, expressed excitement over Choe's leadership and vision for the company's future. Additionally, a webinar led by Merchan on February 11 at 1 PM EST will cover CBD opportunities in North America, Latin America, and the EU.
Flora Growth Corp. (NASDAQ: FLGC) has filed a provisional patent application for a cannabinoid-based formula aimed at preventing SARS-CoV-2 infection. The company is seeking INVIMA (Colombian FDA) approval to advance this product through clinical trials. If successful, this formulation would mark the first cannabinoid product approved in Colombia for COVID-19 use. Flora Pharma, the research division, will conduct the study in a GMP-certified lab in Colombia, exploring potential therapeutic applications of cannabinoids against the virus.
Flora Growth Corp. (NASDAQ: FLGC) has appointed Joël Reyes as Senior Vice President of Global Operations. With extensive experience in operations management, Reyes aims to enhance operational excellence starting with Flora's Colombian activities. The company is leveraging new laws allowing the export of dried cannabis flower and has received an export quota of 7,900 kilograms. This strategic move is expected to ramp up production and meet growing demand. Flora's recent acquisitions also support its global expansion strategy.
Flora Growth Corp. (NASDAQ: FLGC) appointed Derek Pedro, a renowned cannabis genetics and cultivation expert, as an advisor to its Cosechemos cultivation facility. With over 30 years of experience and a track record of developing successful cannabis strains, Pedro will enhance Flora's high-THC and high-CBD offerings for domestic and international markets. This appointment coincides with Flora's expansion efforts and the recent completion of its EU-GMP compliant extraction lab, aiming to optimize operations in Colombia's favorable cultivation environment.
Flora Growth Corp. announced the completion of its 10,500 ft2 extraction facility via its subsidiary Cosechemos, enhancing its annual distillate capacity to 15,000 L. The first batch of High-THC crude oil has been extracted and submitted for the 2022 quota. Cosechemos is also beginning the EU-GMP certification process, allowing potential export of medical-grade cannabis derivatives. The facility aims to improve product offerings while leveraging low-cost outdoor cultivation, targeting growth in the expanding global cannabis derivatives market.
Flora Growth Corp. has appointed Tim Leslie as the Chairman of its new Advisory Board, enhancing its leadership in the cannabis industry. Leslie brings vast experience from his tenure at Amazon and as CEO of Leafly. His role will involve providing strategic counsel to facilitate Flora's international growth, particularly in relation to current clinical trials aimed at developing plant-based medications. The establishment of the Advisory Board aligns with Flora's commitment to assemble a robust leadership team to drive its corporate strategy and market expansion.
Flora Growth Corp. (NASDAQ: FLGC) announces the launch of its Mind Naturals skincare brand on Walmart.com and Coppel in Mexico. The initial offering includes 12 products, expanding their international presence following recent exports to Mexico and Spain. With the global cannabis market projected to exceed $102 billion by 2026, Mexico is expected to see significant CBD product commercialization. CEO Luis Merchan emphasized the company's intent to strengthen its foothold in the plant-based wellness sector, leveraging its sustainable CBD offerings.
Flora Growth Corp. (NASDAQ: FLGC) will hold a webinar on December 14 at 4:30 p.m. ET, featuring CEO Luis Merchan. The session will cover the company's 2021 operational performance and provide 2022 revenue guidance of US$35-45 Million. Participants can register and submit questions in advance. Flora is recognized for its outdoor cannabis cultivation and manufacturing practices, supplying products across various sectors, including cosmetics and food.
Flora Growth Corp. (NASDAQ: FLGC) announced its subsidiary, Vessel Brand, is launching a new line of dry herb consumption products, enhancing its cannabis product offerings. The highlight is the Helix, a patent-pending one-hitter designed for smoother inhalation. Vessel's Eclipse Kit offers an all-in-one experience with customizable options. Upcoming products include a designer ashtray and a precision-engineered grinder. CEO James Choe emphasized the commitment to innovation in the cannabis market. A webinar is scheduled for December 14 to discuss 2021 performance and 2022 financial guidance.